ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $4,673,631 | 14.75% |
| Nextech Invest Ltd. | 4,285,714 | $33,257,141 | 11.30% |
| Column Group LLC | 3,568,181 | $27,689,085 | 10.75% |
| Prosight Management, LP | 5,522,936 | $42,857,984 | 6.42% |
| Invus Financial Advisors, LLC | 1,007,575 | $7,818,782 | 4.18% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,450,822 | $11,258,379 | 3.48% |
| VR Adviser, LLC | 2,142,856 | $16,628,563 | 2.66% |
| Euclidean Capital LLC | 747,550 | $5,800,988 | 1.49% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $16,628,555 | 0.99% |
| Monaco Asset Management SAM | 378,222 | $2,935,003 | 0.82% |